Filter by: patients
What is Systane Eye Drops?

Lubricant Eye Drops designed to reduce both signs (what the eye doctor can measure) and symptoms (what you feel and experience) of dry eye.

Alcon, Inc.'s Systane Eye Drops site

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Dry eyes 15 2 Efficacy_major Efficacy_moderate
Other 5 1 Efficacy_moderate
Itchy eyes 3 1 Efficacy_none
Vision 3 0
General health 1 0
Conjunctivitis 1 0

See all 24 patients currently taking Systane Eye Drops

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
3

Reported Dosages

  1other as needed 2other as needed preserved as needed daily
  1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7 14 Number of Patients: 14  

Reported Stop Reasons

Why Patients Stopped Taking Systane Eye Drops (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 2   Expense: 67%
Did not seem to work 1   Did not seem to work: 33%
Doctor's advice 1   Doctor's advice: 33%
Other 1   Other: 33%

See all 3 patients who’ve stopped taking Systane Eye Drops

Currently Taking Systane Eye Drops

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Systane Eye Drops

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Systane Eye Drops

Always
0 0%
Usually
2 50%
Sometimes
2 50%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Systane Eye Drops

Very
0 0%
Somewhat
0 0%
A little
2 50%
Not at all
2 50%

Cost

Paid out of pocket

Cost of Systane Eye Drops

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 50%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.